The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians, academicians,...
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Men face more diabetes complications than women
May 17, 2024
The findings were independent of diabetes duration over a 10-year period.
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Nerve decompression may ease painful diabetic peripheral neuropathy
Mar 28, 2024
Nerve decompression was associated with reduced pain, but equal improvement was seen in decompressed and sham legs.
Fresh, delivered produce tied to improvements in CVD risk factors
Mar 22, 2024
Significant improvements were seen for produce consumption, physical activity, non-high-density lipoprotein cholesterol and HbA1c.
Disease knowledge limited among individuals with type 2 diabetes
Mar 13, 2024
The item with lowest percentage of correct answers (4.4%) was related to identification of signs of ketoacidosis.
Diabetic retinopathy tied to lower vision-related quality of life
Feb 06, 2024
Greater declines in quality of life were seen for higher-severity diabetic retinopathy.
Modifiable risk factors tied to young-onset dementia
Dec 28, 2023
Some of the factors include social isolation, diabetes, heart disease, vitamin D deficiency, high C-reactive protein and low handgrip strength.
Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D
Dec 27, 2023
Dapagliflozin, however, does not reduce the urinary albumin-to-creatinine ratio in those patients.